The saliva In Vitro Diagnostics (IVD) testing solution is designed to meet different demands of multiple industry segments. The Saliveomix™ platform is engineered to enable multi-product solution, with opportunities as Companion Diagnostic Device (CDx) solution with dedicated treatment.

​

The Saliveomix™ platform incorporates patent protected novel biomarkers, coupled with established saliva proteomics detection technology, producing highly accurate early risk of Heart Failure detection products.

​

The novel biomarkers were originated from research study during the past 10+ years. The panel of biomarkers has since evolved with continuous study and development, in conjunction to technological and data science progression.